科美诊断 (688468.SH) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	324.7M	332.7M	436.3M	445.3M	465.3M
Cost of Revenue	112.8M	111.5M	110.4M	109.7M	119.3M
Gross Profit	211.9M	221.2M	325.9M	335.6M	346.0M
Operating Expenses
R&D Expense	73.2M	73.3M	75.8M	65.8M	68.9M
SG&A Expense	—	—	—	—	—
General & Admin Expense	44.4M	44.5M	52.7M	40.5M	40.0M
Selling & Marketing Expense	56.6M	60.6M	81.8M	92.3M	94.7M
Other Expenses	—	—	—	—	—
Total Operating Expenses	174.8M	180.3M	214.0M	197.2M	203.8M
Cost and Expenses	287.7M	291.8M	324.4M	306.9M	323.0M
Operating Income (EBIT)	45.7M	49.7M	134.7M	166.3M	170.3M
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	—	—	—	—	—
Net Interest Income	—	—	—	—	—
Other Non-Op Income/Expense	—	—	—	—	—
Non-Operating Income (excl Interest)	—	—	—	—	—
EBT (Pre-Tax Income)	45.8M	49.8M	137.9M	166.1M	177.4M
Income Tax Expense	7.5M	5.9M	10.8M	18.7M	24.7M
Bottom Line
Net Income	38.3M	43.9M	127.1M	147.4M	152.6M
Earnings from Cont. Ops	38.3M	43.9M	127.1M	147.4M	152.6M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	38.3M	43.9M	127.1M	147.4M	152.6M
Per Share
Basic EPS	CN¥0.09	CN¥0.11	CN¥0.32	CN¥0.37	CN¥0.38
Diluted EPS	CN¥0.09	CN¥0.11	CN¥0.32	CN¥0.37	CN¥0.38
Revenue Per Share	CN¥0.72	CN¥0.83	CN¥1.10	CN¥1.12	CN¥1.16
Shares
Basic Shares Outstanding	448.0M	399.2M	397.1M	398.3M	401.6M
Diluted Shares Outstanding	448.0M	399.2M	397.1M	398.3M	401.6M
Profitability Metrics
EBITDA	—	101.5M	185.5M	206.8M	213.4M
D&A	—	51.8M	50.7M	40.5M	43.1M
EBIT	—	—	—	—	—

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026